

PEM Currents: The Pediatric Emergency Medicine Podcast
Brad Sobolewski
PEM Currents is a Pediatric Emergency Medicine focused podcast hosted by Brad Sobolewski
Episodes
Mentioned books

Oct 6, 2020 • 13min
Toxicology Season 1 Episode 3: Acetaminophen
This is episode three of season one of the Toxicology series that Suzan Mazor, the Medical Director for Toxicology at Seattle Children’s, and I are putting together. This episode focuses on one of the most common intentional ingestions – Acetaminophen. For those of you from across the ocean – this episode tackles paracetamol, and for […]

Sep 29, 2020 • 13min
Toxicology Season 1 Episode 2: Decontamination and Elimination
This is episode 2 of season one of the Toxicology series that Suzan Mazor, the Medical Director for Toxicology at Seattle Children’s, and I are putting together. This follow up episode focuses on a decontamination and elimination in the poisoned pediatric patient and offers many pearls that will serve as a foundation for upcoming episodes […]

Sep 22, 2020 • 18min
Toxicology Season 1 Episode 1: General approach to the poisoned patient
This is episode 1 of season one of the Toxicology series that Suzan Mazor, the Medical Director for Toxicology at Seattle Children’s, and I are putting together. This premiere episode focuses on a solid general approach to the poisoned pediatric patient and offers many pearls that will serve as a foundation for upcoming episodes. Follow […]

Jul 14, 2020 • 15min
Mastoiditis
Does mastoiditis always present with the classic triad of swelling behind the ear, otalgia, and protrusion of the auricle? Do you need to get a CT to make the diagnosis? What is the exact relationship with acute otitis media? Can swimmer’s ear turn into mastoiditis? These questions and more are why I recorded this episode […]

Jun 9, 2020 • 15min
Delirium
Yes, PEM Currents is a Pediatric Emergency Medicine podcast, but during the COVID-19 pandemic we may be tasked with seeing patients outside of our area of expertise. Plus, there’s a lot we can learn from big people that we can extrapolate to children. I have partnered with POPCoRN, the Pediatric Overflow Planning Contingency Response Network to deliver […]

May 21, 2020 • 15min
Multisystem Inflammatory Syndrome in Children
Multisystem Inflammatory Syndrome in Children (MIS-C) is an evolving clinical entity that is occurring, possibly in association with or following a COVID-19 infection. This episode of PEM Currents expands upon a recent PEMBlog post, as well as includes information from two studies published in The Lancet as well as included in a recent CDC webinar. […]

May 14, 2020 • 20min
Pulmonary Embolism
Yes, PEM Currents is a Pediatric Emergency Medicine podcast, but during the COVID-19 pandemic we may be tasked with seeing patients outside of our area of expertise. Plus, there’s a lot we can learn from big people that we can extrapolate to children. I have partnered with POPCoRN, the Pediatric Overflow Planning Contingency Response Network to deliver […]

May 5, 2020 • 0sec
Vasopressors
Vasopressor use in the Pediatric Emergency Department has been a moving target for my entire career. Back when I was a resident and fellow we used Dopamine. Then we went to epinephrine because it can be given through a peripheral IV because norepinephrine was too dangerous to run peripherally. But maybe that’s not entirely true. […]

Apr 22, 2020 • 14min
Stroke in Adults
Yes, PEM Currents is a Pediatric Emergency Medicine podcast, but during the COVID-19 pandemic we may be tasked with seeing patients outside of our area of expertise. Plus, there’s a lot we can learn from big people that we can extrapolate to children. I have partnered with POPCoRN, the Pediatric Overflow Planning Contingency Response Network to deliver […]

Mar 25, 2020 • 0sec
Status Epilepticus
Status epilepticus can be very stressful in the Pediatric Emergency Department. This episode of PEM Currents: The Pediatric Emergency Medicine Podcast focuses on management, and will guide you through the treatment process, starting with benzodiazepines, followed by a discussion of the recent evidence for second line therapy between fosphenytoin, levetiracetam, and valproate. Follow me on […]